http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019108076-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76ca83e74cf4875696f8bfc42d1cf316
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b057fddee6645785fc5df7006be3bb3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2001-4016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2201-06113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-347
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-4077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-4005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-493
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-65
filingDate 2018-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7801fba620cf34e359708a5b3bd14a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc50913de8fcaf9cb67cf4439dbf19bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe8d26860c04a4f456532ce4b8200595
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21abcc53b94058a53b4d547042defbf6
publicationDate 2019-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2019108076-A1
titleOfInvention A method of detecting and diagnosing the progression of diabetes
abstract The subject of the invention is the method of detecting and diagnosing the progression of diabetes using Raman spectroscopy which involves the examination of the changes in the composition of urinary extracellular vesicles which confirm the existence of the condition and its progression. The invention can be applied in clinical practice, in particular in the early clinical diagnostics of diabetes and in the monitoring of its progression, in particular diabetic nephropathy and advanced renal impairment caused by diabetes.
priorityDate 2017-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449391796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411211448
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4070891
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449434161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531276

Total number of triples: 40.